J Cachexia Sarcopenia Muscle
February 2025
Background: Sarcopenia, characterized by a gradual decline in skeletal muscle mass and function with age, significantly impacts both quality of life and mortality. Autophagy plays a crucial role in maintaining muscle health. There is growing interest in leveraging autophagy to mitigate muscle ageing effects.
View Article and Find Full Text PDFBackground: For restorative demands, increased vertical dimension of occlusion (VDO) is sometimes necessary, as facial changes can be perceptible.
Objectives: This study aimed to evaluate the perception of facial change due to increased VDO and associated soft tissue changes using 3D-scanned facial images.
Methods: Forty participants with healthy dentition and no loss of VDO were recruited.
J Hazard Mater
January 2025
The presence of cobalt ions (Co) and radionuclides (Co) in industrial and radioactive effluents pose serious threats to environmental ecosystems and human health. This paper presents the synthesis of dual-functional hydroxyapatite (HAp)-incorporated spherical carbon (SC) composite (HAp/SC) towards the selective adsorption of cobalt from wastewater and the utilization of the Co-adsorbed HAp/SC composite (Co- HAp/SC) as an electrocatalyst for the oxygen evolution reaction (OER). Herein, we prepared a series of HAp/SC composites by varying HAp weight percentages of 10 %, 20 %, 30 %, 40 %, and 50 %.
View Article and Find Full Text PDFCPT Pharmacometrics Syst Pharmacol
January 2025
Ritlecitinib is an orally bioavailable, small molecule that has been approved by the U.S. Food and Drug Administration (FDA) as a once-daily oral treatment option for people 12 years of age and older with severe alopecia areata.
View Article and Find Full Text PDF